Jefferies initiated coverage on ASLAN Pharmaceuticals with a new price target
$ASLN
Biotechnology: Pharmaceutical Preparations
Health Care
Jefferies initiated coverage of ASLAN Pharmaceuticals with a rating of Buy and set a new price target of $8.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/9/2021 | $8.00 | Buy | Jefferies |
25-NSE - ASLAN Pharmaceuticals Ltd (0001722926) (Subject)
SCHEDULE 13G/A - ASLAN Pharmaceuticals Ltd (0001722926) (Subject)
6-K - ASLAN Pharmaceuticals Ltd (0001722926) (Filer)